Wikidata

(Q64950614)

English

A phase 1 ascending dose study of a subcutaneously administered factor IXa inhibitor and its active control agent.

scientific article published in July 2012

In more languages
default for all languages
No label defined

No description defined

Statements

title
A phase 1 ascending dose study of a subcutaneously administered factor IXa inhibitor and its active control agent. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22500821
retrieved
1 July 2019
reference URL
http://europepmc.org/abstract/MED/22500821

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64950614&oldid=1049978211"